After the medication
Existing GLP-1 apps focus on injections, reminders, and side effects. Once users stop, those tools become irrelevant.
Coming soon
You lost the weight. Now rebuild your body.
A post-GLP-1 tracker for muscle, protein, strength consistency, and progress beyond the scale.
- Track regain risk without scale obsession
- Hit protein and strength goals with simple daily check-ins
- See body recomposition progress week to week
Weekly Snapshot
Consistency beats panic.
Protein goal
102g / 120g
Training
3 days
Waist
-0.5 in
Trend
Stable
Mood
Hopeful
Your weight is slightly up while your waist is down. That can
be a sign of recomposition, not failure.
Built for life after Ozempic®, Wegovy®, Mounjaro®, and Zepbound®
Why this exists
The support disappears right when users need it most.
Body changes feel confusing
Weight fluctuations, muscle loss, loose skin, and rising appetite can all happen at once. Generic fitness apps do not explain what any of it means.
People need signal, not shame
The goal is not calorie obsession. It is clear tracking, trustworthy education, and a better way to see progress.
Core benefits
What AFTERGLPSHOT helps users do
Track beyond the scale
Weight trends, measurements, progress photos, and weekly reports give a fuller picture of what is changing.
Stay consistent with what matters
Quick daily tracking keeps protein intake, hydration, and strength consistency visible without turning into a full macro app.
Understand what is happening
Research-backed education helps users make sense of regain fears, body recomposition, and the transition off GLP-1s.
Premium plan
A focused post-GLP-1 toolkit for the transition ahead.
Everything you need to protect your progress after GLP-1s. Simple tracking, weekly insights, and research-backed guidance.
Early access
Join the waitlist
Get launch updates and the first month free when early access opens.
AFTERGLPSHOT is an educational tracking concept, not a medical device. It does not provide medical advice, diagnosis, or treatment. Consult your healthcare provider before making changes to your health routine.
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly.